Search results for " OSTEOPOROSI"

showing 10 items of 110 documents

Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparat…

2013

Objectives: The aim of this study is to describe and compare the evolution of recurrent bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients treated with plasma rich in growth factors or teriparatide. Material and Methods: Two different types of treatments were applied in patients diagnosed of recurrent BRONJ in a referral hospital for 1.100.000 inhabitants. In the group A, plasma rich in growth factors was applied during the surgery. In the group B, the treatment consisted in the subcutaneous administration of teriparatide. All the cases of BRONJ should meet the following conditions: recurrent BRONJ, impossibility of surgery in stage 3 Ruggiero classification and absence of…

medicine.medical_specialtyOdontologíaPilot ProjectsGroup AGroup BFibrinTeriparatidemedicineTeriparatideHumansStage (cooking)General DentistryAgedAged 80 and overFibrinBisphosphonate-associated osteonecrosis of the jawOral bisphosphonatesOral Medicine and PathologybiologyBone Density Conservation Agentsbusiness.industryResearchMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASbiology.proteinIntercellular Signaling Peptides and ProteinsSurgeryPrimary osteoporosisBisphosphonate-Associated Osteonecrosis of the JawFemalebusinessmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

Osteoporosis in men: a case report

2010

Osteoporosis in men is frequently not considered, underdiagnosed and often undertreated. In contrast with osteoporosis occurring in women, the genesis is frequently secondary (30-60%) with a complex diagnostic approach. A careful anamnesis and physical examination associated with laboratory and instrumental evaluation are necessary for an accurate diagnosis. The clinical case presented concerns a 70-year-old man with negative family history for osteoporosis and a personal history of depression, HBV carrier, and chronic obstructive pulmonary disease (COPD) in a heavy ex-smoker with history of alcoholism. The comprehensive geriatric evaluation allowed us to diagnose a multifactorially seconda…

medicine.medical_specialtyPediatricsAlcohol abuseOsteoporosisMedicine (miscellaneous)Alcohol abusePhysical examinationMale osteoporosis; Alcohol abuse; Osteomalacia; Malnutrition; Chronic obstructive pulmonary diseaseMedicineMale osteoporosisFamily historyDepression (differential diagnoses)COPDOsteomalacialcsh:R5-920medicine.diagnostic_testbusiness.industryChronic obstructive pulmonary diseaseMalnutritionmedicine.diseaseOsteomalaciaPhysical therapyBusiness Management and Accounting (miscellaneous)Secondary osteoporosisClinical Medicinebusinesslcsh:Medicine (General)Clinical Management Issues
researchProduct

Kümmell's Disease: Clarifying the Mechanisms and Patients' Inclusion Criteria.

2014

The three major causes of vertebral body collapse include infection, malignant neoplasia, and trauma and it may be difficult to distinguish between them, particularly in the presence of severe osteoporosis. In 1891, however, Dr Hermann Kümmell, further added another possibility of vertebral body crush; the delayed posttraumatic collapse. As originally described, this rare clinical entity includes patients, who after a trivial trauma and an asymptomatic clinical course they develop a progressive vertebral body collapse and a painful kyphosis. Although more than a century has passed from its initial description, only few cases have been reported in the literature, whereas the main pathologic …

medicine.medical_specialtyPediatricsbusiness.industryKyphosisTime lagvertebral body collapseDiseasemedicine.diseaseAsymptomaticArticleSurgeryIntravertebral vacuum cleftresearch reviewKummell's diseasePathognomonicmedicineKümmell’s diseaseSevere osteoporosismedicine.symptomvertebral osteonecrosis.businessCollapse (medical)The open orthopaedics journal
researchProduct

AB1390 Osteoporosis associated morbidity analysis can reveal targets for better disease diagnosis and management

2018

Background Osteoporosis accounts for more disability and life years lost than rheumatoid arthritis. It brings an elevated risk of mortality, morbidity and re-/hospitalisation due to fractures and a significant financial and social burden. A rationale use of diagnostic and therapeutic resources is useful and should be encouraged at all intervention levels. For admitted patients, clinical risk factors for fractures and conditions that are causes for secondary osteoporosis should trigger either the diagnosis approach or the referral to a (Rheumatology/Endocrinology) specialist and treatment should be started during hospitalisation. Objectives We aimed to identify targets for educational or pro…

medicine.medical_specialtyPediatricsbusiness.industryMedical recordOsteoporosisDiseasemedicine.diseaseRheumatologyInternal medicineEpidemiologyRisk of mortalityMedicineSecondary osteoporosisbusinessLiterature surveyEducation
researchProduct

The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?

2009

Osteoporosis is a chronic disease that accelerates after menopause in many women. Most of the pharmacologic attempts to control the disease, such as hormone therapy, have emphasized the constraint of bone resorption. Since recent years have witnessed important advances in the field of bone formation, this review aims to update the present knowledge on the mechanisms affecting osteoblastogenesis and on the therapeutic results achieved by recently approved drugs.We sought peer-reviewed, full-length basic and clinical articles published between 1995 and May 2008 using a PubMed search strategy, with the terms osteoporosis and osteoblast, osteoporosis and strontium ranelate, and osteoporosis and…

medicine.medical_specialtyPediatricsmedicine.medical_treatmentOsteoporosisThiophenesDiseasePostmenopausal osteoporosisFractures BoneStrontium ranelateOsteogenesisOrganometallic CompoundsmedicineAnimalsHumansBone formationOsteoporosis PostmenopausalAgedOsteoblastsBone Density Conservation Agentsbusiness.industryObstetrics and GynecologyCell DifferentiationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryMenopauseChronic diseaseGene Expression RegulationParathyroid HormoneFemaleHormone therapybusinessmedicine.drugClimacteric
researchProduct

Determinants of adherence to osteoporosis treatment in clinical practice.

2006

Introduction: Poor adherence to prescribed treatments is widespread in clinical practice and this can lead to potentially life-threatening events. This problem is apparently very common for osteoporosis treatment but the causes of discontinuation and low compliance are complex and poorly defined. Methods: Global adherence to osteoporosis treatment was specifically addressed in a nation-wide survey carried out in 9851 postmenopausal women referred to 141 Italian centres for osteoporosis management for a follow-up assessment, at least one year after having been prescribed a treatment with one of the following drugs: calcium±vitamin D supplements alone (CaVitD), hormone replacement therapy (HR…

medicine.medical_specialtySettore MED/09 - Medicina InternaHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisosteoporosis; Determinants; Treatment adherence; Treatmentadherence; compliance; osteoporosis; persistence; treatmentInternal medicinemedicineTreatment adherenceHumansRaloxifeneDosingVitamin DDeterminantsOsteoporosis PostmenopausalAgedAdherence Compliance Osteoporosis Persistence TreatmentBone Density Conservation Agentsbusiness.industryHormone replacement therapy (menopause)Middle Agedmedicine.diseaseosteoporosisRheumatologyDiscontinuationMenopauseTreatmentItalyOrthopedic surgeryPhysical therapyPatient ComplianceCalciumFemalebusinessmedicine.drugOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
researchProduct

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis

2021

Abstract Denosumab is associated with the development of medication-related osteonecrosis of the jaw (MRONJ), an uncommon but severe oral side effect with a higher prevalence in metastatic cancer patients than in patients with metabolic bone fragility. Although several oral triggers can initiate MRONJ, invasive oral treatments and tooth extraction still remain the most common precipitating event. In general, tooth extraction and oral surgery should be avoided in patients at increased risk of MRONJ, while extraction of non-restorable teeth should be performed based on specific risk reduction protocols to eliminate dental/periodontal infections, still protecting from MRONJ onset. Based on th…

medicine.medical_specialtySide effectOsteoporosisSpecialties of internal medicine030209 endocrinology & metabolismMRONJOral surgery tooth extraction03 medical and health sciences0302 clinical medicineOral surgeryMedication-related osteonecrosis of the jawmedicineDenosumab osteoporosis; Medication-related osteonecrosis of the jaw; MRONJ; Oral surgery tooth extraction; Denosumab; Diphosphonates; Humans; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; OsteoporosisHumansIntensive care medicineGeneral Dentistrytooth extractionBisphosphonate-associated osteonecrosis of the jawDiphosphonatesBone Density Conservation Agentsbusiness.industryHypothesismedicine.diseaseosteoporosisDenosumab osteoporosisBone Density Conservation Agentsstomatognathic diseasesDenosumabOtorhinolaryngologyRC581-951030220 oncology & carcinogenesisDental surgeryOral and maxillofacial surgeryBisphosphonate-Associated Osteonecrosis of the JawNeurology (clinical)DenosumabbusinessOsteonecrosis of the jawmedicine.drugHead & Face Medicine
researchProduct

Duration of breastfeeding as a risk factor for vertebral fractures

2014

Abstract Purpose Among the risk factors for osteoporosis and fractures, gynecological history (fertile period, parity and breastfeeding) play an important part. Changes in calcium metabolism to enable an adequate mineral transfer to the milk have a prominent role in bone loss during breastfeeding. Data on the influence of breastfeeding in postmenopausal osteoporosis are inconsistent. The aim of the present study was to identify any association between duration of breastfeeding and vertebral fractures in postmenopausal women. Methods All patients underwent the following tests: bone mineral density measurements of the lumbar spine (L1–L4) and the total and femoral neck using dual-energy X-ray…

medicine.medical_specialtyTime FactorsHistologyPhysiologybreastfeedingEndocrinology Diabetes and MetabolismOsteoporosisBreastfeedingcalcium metabolismPregnancyRisk FactorsLactationConfidence IntervalsOdds RatiomedicineHumansvertebral fracturesRisk factorFemoral neckBone mineralPregnancybusiness.industryObstetricsrisk factors for osteoporosiMiddle Agedmedicine.diseaseSurgeryMenopauseBreast Feedingmedicine.anatomical_structureSpinal FracturesFemalebusiness
researchProduct

Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: A retrospective multi-hospital-based study of 87 Italian cases

2013

Abstract Background Bisphosphonates (BPs) are currently the chief drugs for the prevention/treatment of osteoporosis; one of their adverse effects is the osteonecrosis of the jaw (BRONJ). The primary endpoints of this multi-center cross-sectional study are: i) an observation of the clinical features of BRONJ in 87 osteoporotic, non-cancer patients; and ii) an evaluation of their demographic variables and comorbidities. Methods 87 BRONJ patients in therapy for osteoporosis with BPs from 8 participating clinical Italian centers were consecutively identified and studied. After BRONJ diagnosis and staging, comorbidities and data relating to local and drug-related risk factors for BRONJ were col…

medicine.medical_specialtyTime FactorsMultivariate analysisHeart DiseasesOsteoporosisSettore MED/50 - Scienze Tecniche Mediche ApplicateAdministration OralMandibleOsteonecrosis jawHospital based studyAdrenal Cortex HormonesRisk FactorsSettore MED/28 - Malattie OdontostomatologicheInternal medicineDiabetes MellitusInternal MedicinemedicineHumansIn patientRisk factorOral bisphopshonateAdverse effectOsteoporosis PostmenopausalAgedRetrospective StudiesAged 80 and overAlendronateBone Density Conservation AgentsDiphosphonatesbusiness.industryLiver DiseasesIncidence (epidemiology)Age FactorsMiddle Agedmedicine.diseaseSurgeryCross-Sectional StudiesItalyOral bisphopshonates; Osteonecrosis jaws; OsteoporosisHypertensionMultivariate AnalysisOsteoporosisBisphosphonate-Associated Osteonecrosis of the JawFemaleOsteonecrosis of the jawbusiness
researchProduct

Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis

2020

Objective: Musculoskeletal functional deterioration in Amyotrophic lateral sclerosis (ALS) is associated with an increase in bone fractures. The purpose of this study was to evaluate the influence of sex, ALS type, on bone quality in patients with ALS compared to healthy controls. The impact on bone health of the clinical status and some metabolic parameters was also analyzed in ALS patients.Methods: A series of 33 voluntary patients with ALS, and 66 healthy individuals matched in sex and age underwent assessment of bone mass quality using quantitative ultrasound (QUS) of the calcaneus. Ultrasonic broadband attenuation (BUA), the speed of sound (SOS), stiffness index and T-score were measur…

medicine.medical_specialtyamyotrophic lateral sclerosisOsteoporosisvitamin DPhysical strengthGastroenterologylcsh:RC346-429Pulmonary function testingFEV1/FVC ratioInternal medicinemedicineVitamin D and neurologyAmyotrophic lateral sclerosisamyotrophic lateral sclerosis bone quality neurodegeneration osteoporosis quantitative ultrasound (QUS) measurement vitamin DOssos Malaltieslcsh:Neurology. Diseases of the nervous systemBone mineralquantitative ultrasound (QUS) measurementbusiness.industryneurodegenerationBrief Research Reportmedicine.diseaseosteoporosisbone qualityNeurologyCalcaneusNeurology (clinical)business
researchProduct